Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Unity Biotechnology Inc (NQ: UBX )

6.830 USD +0.120 (+1.79%)
Official Closing Price Updated: 7:56 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Unity Biotechnology Inc

< Previous 1 2 Next >
Ascentage Pharma's Licensee UNITY Biotechnology Announces Milestone Reached in Clinical Development of Treatments for Age-Related Disease, Leading to Milestone Payment
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today... 
From PR Newswire
UNITY Biotechnology Reports Granting of New Employment Inducement Awards
From GlobeNewswire News Releases
UNITY Biotechnology Announces Appointment of Clinical Development and Industry Veteran Gilmore O’Neill, M.B., to the Board of Directors
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. Reports Third Quarter 2020 Financial Results and Clinical Program Updates
From GlobeNewswire News Releases
UNITY Biotechnology Announces First Patient Dosed in Phase 1 Study of UBX1325 in Diabetic Macular Edema
From GlobeNewswire News Releases
UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology
From GlobeNewswire News Releases
UNITY Biotechnology to Participate in Upcoming September Investor Conferences
From GlobeNewswire News Releases
UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial Officer
From GlobeNewswire News Releases
Thinking about buying stock in Immatics NV, Biocept Inc, LMP Automotive, Unity Biotechnology, or Barrick Gold Corp?
InvestorsObserver issues critical PriceWatch Alerts for IMTX, BIOC, LMPX, UBX, and GOLD. 
From PR Newswire
UNITY Biotechnology Announces 12-week data from UBX0101 Phase 2 Clinical Study in Patients with Painful Osteoarthritis of the Knee
From GlobeNewswire News Releases
UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
From GlobeNewswire News Releases
UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
UNITY Biotechnology Announces CFO Transition
Lynne Sullivan appointed interim chief financial officer 
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs
From GlobeNewswire News Releases
UNITY Biotechnology to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference
From GlobeNewswire News Releases
UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results
From GlobeNewswire News Releases
UNITY Biotechnology Completes Enrollment in Phase 1b Study of UBX0101
– Topline 12- and 24-week results expected in 2H 2020 – 
From GlobeNewswire News Releases
UNITY Biotechnology Announces Start of New CEO and New Employment Inducement Grants
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results
From GlobeNewswire News Releases
UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer
From GlobeNewswire News Releases
UNITY Biotechnology Provides Pipeline and Business Updates
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates
From GlobeNewswire News Releases
UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee
From GlobeNewswire News Releases
Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results
From GlobeNewswire News Releases
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.